Krensavage Asset Management, LLC Long-Term Concentrated

CIK: 0001609251 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $320,818 (100.0% shares, 0.0% debt)

Holdings (16)

ENTA ENANTA PHARMACEUTICALS INC 15.9%
Value ($000) $50,862 Shares 866,770 Est. Cost $35.70 Unrealized +40.2%
UTHR UNITED THERAPEUTICS CORP 13.6%
Value ($000) $43,561 Shares 294,429 Est. Cost $133.07 Unrealized -4.5%
BIOVERATIV INC 12.3%
Value ($000) $39,376 Shares 730,260 Est. Cost $54.39 Unrealized
GILD GILEAD SCIENCES INC 10.7%
Value ($000) $34,248 Shares 478,053 Est. Cost $52.64 Unrealized +6.2%
SUCAMPO PHARMACEUTICALS-CL A 7.3%
Value ($000) $23,414 Shares 1,304,376 Est. Cost $11.89 Unrealized
MCK MCKESSON CORP 6.1%
Value ($000) $19,725 Shares 126,482 Est. Cost $138.91 Unrealized 0.0%
INVACARE CORP 5.8%
Value ($000) $18,666 Shares 1,107,770 Est. Cost $13.92 Unrealized
HALYARD HEALTH INC 5.7%
Value ($000) $18,242 Shares 395,015 Est. Cost $40.65 Unrealized
RTI SURGICAL INC 5.5%
Value ($000) $17,773 Shares 4,334,852 Est. Cost $4.39 Unrealized
OM2 ORTHOFIX INTERNATIONAL NV 5.5%
Value ($000) $17,742 Shares 324,357 Est. Cost $32.47 Unrealized
AMGN AMGEN INC 4.7%
Value ($000) $15,212 Shares 87,477 Est. Cost $138.21 Unrealized 0.0%
MRK MERCK & CO. INC. 2.8%
Value ($000) $8,973 Shares 159,466 Est. Cost $41.59 Unrealized +3.4%
CNMD CONMED CORP 2.6%
Value ($000) $8,387 Shares 164,547 Est. Cost $38.10 Unrealized +26.7%
JUNIPER PHARMACEUTICALS INC 0.7%
Value ($000) $2,134 Shares 440,102 Est. Cost $7.24 Unrealized
AVIRAGEN THERAPEUTICS INC 0.5%
Value ($000) $1,591 Shares 2,809,531 Est. Cost $1.21 Unrealized
DIGIRAD CORP 0.3%
Value ($000) $912 Shares 354,179 Est. Cost $4.31 Unrealized